2. Tegally H., et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv. doi: https://doi.org/10.1101/2020.12.21.20248640
3. Starr TN., et al. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell. 2020;182(5):1295-1310 e1220.
4. Thomson EC., et al. The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity. bioRxiv. doi: https://doi.org/10.1101/2020.11.04.355842
5. Weisblum Y., et al. Escape from neutralizing antibodies by SARSCoV-2 spike protein variants. Elife. 2020;9:e61312.
6. Greaney AJ., et al. Complete Mapping of Mutations to the SARSCoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition. Cell Host Microbe. 2020.
7. Liu Z., et al. Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. bioRxiv. doi: https://doi.org/10.1101/2020.11.06.372037
8. Baum A., et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science. 2020;369(6506):1014-1018.
9. Piccoli L., et al. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High Resolution Serology. Cell. 2020;183(4):1024-1042 e1021.
13.South Africa Expects 1st Virus Vaccine Delivery by Mid-2021.https://www.bloomberg.com/news/articles/2020-12-05/south-africa-expects-first-virus-vaccine-delivery-by-mid-2021